Beyond the clinic: ‘direct-to-consumer’ genomic profiling services and pharmacogenomics

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.14, Iss.4, 2013-03, pp. : 403-412

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Direct-to-consumer genome testing: opportunities for pharmacogenomics research?

By Prainsack Barbara Wolinsky Howard

Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. : 651-655

Future Medicine

Access to resources Recommend Favorite

Direct-to-consumer pharmacogenomic testing

By Howard Heidi Carmen Borry Pascal

Pharmacogenomics, Vol. 12, Iss. 10, 2011-10 ,pp. : 1367-1370

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics and Personalised Medicine: Consumer Perspectives, Lessons Learned in Australia and Beyond

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 10, Iss. 2, 2012-06 ,pp. : 170-177

Bentham Science Publishers

Access to resources Recommend Favorite

Costs and Benefits of Direct-to-Consumer Advertising: The Case of Depression

By Block Adam E.

PharmacoEconomics, Vol. 25, Iss. 6, 2007-01 ,pp. : 511-521

Adis International

Access to resources Recommend Favorite

Direct-to-consumer ads may be beneficial for aromatase inhibitors

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 668, 2012-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite